BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 5076253)

  • 1. Placental lactogen levels as guide to outcome of threatened abortion.
    Niven PA; Landon J; Chard T
    Br Med J; 1972 Sep; 3(5830):799-801. PubMed ID: 5076253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human placental lactogen (HPL) in serum in complicated early pregnancy.
    Ylikorkala O; Jouppila P
    J Obstet Gynaecol Br Commonw; 1973 Dec; 80(12):1040-5. PubMed ID: 4761378
    [No Abstract]   [Full Text] [Related]  

  • 3. Estradiol, estriol and human placental lactogen in serum in threatened abortion.
    Hertz JB; Larsen JF; Svenstrup B; Johnsen SG
    Acta Obstet Gynecol Scand; 1979; 58(4):365-70. PubMed ID: 525270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human placental lactogen levels in the serum during early pregnancy.
    Dudenhausen R; Dudenhausen JW
    J Perinat Med; 1974; 2(2):93-100. PubMed ID: 4468298
    [No Abstract]   [Full Text] [Related]  

  • 5. Placental lactogen levels in threatened abortion.
    Niven PA; Chard T
    Proc R Soc Med; 1973 Feb; 66(2):188. PubMed ID: 4714661
    [No Abstract]   [Full Text] [Related]  

  • 6. Human placental lactogen, pregnancy-specific beta-1-glycoprotein and alpha-fetoprotein in serum in threatened abortion.
    Hertz JB; Schultz-Larsen P
    Int J Gynaecol Obstet; 1983 Apr; 21(2):111-7. PubMed ID: 6193015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of fetal outcome in threatened abortion by maternal serum placental lactogen and alpha fetoprotein.
    Garoff L; Seppälä M
    Am J Obstet Gynecol; 1975 Jan; 121(2):257-61. PubMed ID: 46714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of human-placental-lactogen radioimmunoassay to predict outcome in cases of threatened abortion.
    Genazzani AR; Aubert ML; Casoli M; Fioretti P; Felber JP
    Lancet; 1969 Dec; 2(7635):1385-7. PubMed ID: 4188275
    [No Abstract]   [Full Text] [Related]  

  • 9. [Human chorionic somato-mammotropin (HCS) in normal early pregnancy and in threatened abortion (author's transl)].
    Melchert F
    Geburtshilfe Frauenheilkd; 1974 Jul; 34(7):515-9. PubMed ID: 4848882
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma hormone profile of threatened abortion and its prognosis.
    Miyakawa I; Ikeda I; Maeyama M
    Int J Gynaecol Obstet; 1977; 15(1):12-6. PubMed ID: 562785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of determinations of human chorionic gonatrophin, human placental lactogen, progesterone and oestriol in women with threatened abortion (author's transl)].
    Gerhard I; Runnebaum B
    Geburtshilfe Frauenheilkd; 1978 Oct; 38(10):785-99. PubMed ID: 700341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Radioimmunological assessment of the placental lactogen concentration in threatened abortion].
    Szymanski W; Przylepa M
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():57-63. PubMed ID: 6242695
    [No Abstract]   [Full Text] [Related]  

  • 13. Human placental lactogen as an index of placental function.
    Zuckerman H; Gendler L; Schwarz M; Harpaz S
    Isr J Med Sci; 1974 May; 10(5):490-4. PubMed ID: 4413719
    [No Abstract]   [Full Text] [Related]  

  • 14. Alpha-fetoprotein: a marker for threatened abortion.
    Sande HA; Fagerhol M; Molnar O; Foss OP; Torjesen P
    Int J Gynaecol Obstet; 1978-1979; 16(4):293-5. PubMed ID: 86467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of human placental lactogen (HPL) levels in threatened abortion.
    Gartside MW; Tindall VR
    Br J Obstet Gynaecol; 1975 Apr; 82(4):303-9. PubMed ID: 1125152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioimmunologic evaluation of the concentration of placental lactogen in threatened abortions].
    Szymanski W; Przylepa M
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():57-63. PubMed ID: 6211055
    [No Abstract]   [Full Text] [Related]  

  • 17. Depressed serum levels of human placental lactogen in first trimester vaginal bleeding.
    Pedersen JF; Ruge S; Sørensen S
    Acta Obstet Gynecol Scand; 1995 Jan; 74(1):27-9. PubMed ID: 7531935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of HPL radioimmunoassay in normal and pathologic early pregnancy].
    Hör G; Wallner H; Pabst HW; Domanowsky W
    Nucl Med (Stuttg); 1975 Jan; 13(4):371-8. PubMed ID: 1114050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Application of radioimmunologic determination of placental lactogen hormone to the prognosis of spontaneous threatened abortion].
    Hechtermans R; L'Hermite-Baleriaux M
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):331-04. PubMed ID: 4681537
    [No Abstract]   [Full Text] [Related]  

  • 20. Can pregnancy-associated plasma protein A (PAPP-A) predict the outcome of pregnancy in women with threatened abortion and confirmed fetal viability?
    Ruge S; Pedersen JF; Sørensen S; Lange AP
    Acta Obstet Gynecol Scand; 1990; 69(7-8):589-95. PubMed ID: 1709769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.